Ineffective therapies for rheumatoid arthritis cost patients more than $2 billion a year, according to a paper in Arthritis and Rheumatology.
That could be changing as scientists use genetic profiling of joint tissue to see which drugs will work for patients, according to a new Northwestern Medicine study.
Instead of a trial and error approach to treating RA, scientists hope to develop genetic profiles to show them which medicines will be most effective.
If you love some fresh produce from a garden, and the fun of watching it grow, you can get quite a bit with a small patch of earth that won’t become a…
If you have just been in isolation for months (or someone you care for has), some basic human needs will have to be renewed upon social opening. – Touch….
The very rich and the very poor have one thing in common: They don’t need long-term care insurance. The rich can pay their way and the poor can rely on…
